KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Discontinued OperationsCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Change in Intangibles: 2012-2022

Historic Change in Intangibles for TherapeuticsMD (TXMD) over the last 11 years, with Dec 2022 value amounting to $95,000.

  • TherapeuticsMD's Change in Intangibles fell 93.73% to $95,000 in Q4 2022 from the same period last year, while for Dec 2022 it was $355,000, marking a year-over-year decrease of 83.78%. This contributed to the annual value of $355,000 for FY2022, which is 83.78% down from last year.
  • Latest data reveals that TherapeuticsMD reported Change in Intangibles of $95,000 as of Q4 2022, which was up 1,457.14% from -$7,000 recorded in Q3 2022.
  • In the past 5 years, TherapeuticsMD's Change in Intangibles ranged from a high of $1.5 million in Q4 2021 and a low of -$7,000 during Q3 2022.
  • In the last 3 years, TherapeuticsMD's Change in Intangibles had a median value of $250,500 in 2020 and averaged $327,917.
  • In the last 5 years, TherapeuticsMD's Change in Intangibles soared by 364.42% in 2021 and then slumped by 102.78% in 2022.
  • Over the past 5 years, TherapeuticsMD's Change in Intangibles (Quarterly) stood at $356,501 in 2018, then rose by 4.76% to $373,458 in 2019, then fell by 12.71% to $326,000 in 2020, then surged by 364.42% to $1.5 million in 2021, then slumped by 93.73% to $95,000 in 2022.
  • Its Change in Intangibles stands at $95,000 for Q4 2022, versus -$7,000 for Q3 2022 and $97,000 for Q2 2022.